Gene · 7307
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biological drivers of clinical phenotype in myelofibrosis. | Leukemia | 2023 | 36434065 | PubTator, text mining | PubMed |
| Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes. | Hematol Oncol | 2023 | 36420747 | PubTator, text mining | PubMed |
| Sex differences in adults with acute myeloid leukemia and the impact of sex on overall survival. | Cancer Med | 2023 | 36419242 | PubTator, text mining | PubMed |
| Mapping the Constrained Coding Regions in the Human Genome to Their Corresponding Proteins. | J Mol Biol | 2023 | 36410474 | PubTator, text mining | PubMed |
| Monocytosis at the time of diagnosis has a negative prognostic impact in myelodysplastic syndromes with less than 5% bone marrow blasts. | Ann Hematol | 2023 | 36409328 | PubTator, text mining | PubMed |
| Molecular characterization of AML-MRC reveals TP53 mutation as an adverse prognostic factor irrespective of MRC-defining criteria, TP53 allelic state, or TP53 variant allele frequency. | Cancer Med | 2023 | 36394085 | PubTator, text mining | PubMed |
| Association of genetic variants and survival in patients with acute myeloid leukemia in rural Appalachia. | Cancer Rep (Hoboken) | 2023 | 36382570 | PubTator, text mining | PubMed |
| CNL and aCML should be considered as a single entity based on molecular profiles and outcomes. | Blood Adv | 2023 | 36375042 | PubTator, text mining | PubMed |
| Genetic basis and molecular profiling in myeloproliferative neoplasms. | Blood | 2023 | 36347013 | PubTator, text mining | PubMed |
| Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials. | Haematologica | 2023 | 36325893 | PubTator, text mining | PubMed |
| ASCancer Atlas: a comprehensive knowledgebase of alternative splicing in human cancers. | Nucleic Acids Res | 2023 | 36318242 | PubTator, text mining | PubMed |
| Co-mutation landscape and clinical significance of RAS pathway related gene mutations in patients with myelodysplastic syndrome. | Hematol Oncol | 2023 | 36316121 | PubTator, text mining | PubMed |
| Genomic alterations in a cohort of pediatric acute myeloid leukemia patients at two cancer centers in Colombia. | Int J Hematol | 2023 | 36279042 | PubTator, text mining | PubMed |
| HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation. | Cell Mol Gastroenterol Hepatol | 2023 | 36244648 | PubTator, text mining | PubMed |
| JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome. | J Cancer Res Clin Oncol | 2023 | 36242602 | PubTator, text mining | PubMed |
| Idiopathic splanchnic vein thrombosis: is it really idiopathic? | Haematologica | 2023 | 36226492 | PubTator, text mining | PubMed |
| Clonal hematopoiesis in patients with stem cell mobilization failure: a nested case-control study. | Blood Adv | 2023 | 36219593 | PubTator, text mining | PubMed |
| Splicing factor mutations in the myelodysplastic syndromes: Role of key aberrantly spliced genes in disease pathophysiology and treatment. | Adv Biol Regul | 2023 | 36216757 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Sex and the basal mRNA synthesis machinery. | Wiley Interdiscip Rev RNA | 2023 | 36195437 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7307/papers?page=34